Multifaceted roles of cyclooxygenase-2 in lung cancer
K Riedl, K Krysan, M Põld, H Dalwadi… - Drug resistance …, 2004 - Elsevier
Lung cancer is the leading cause of cancer death in the United States. Although the low 5-
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …
[PDF][PDF] Multifaceted roles of cyclooxygenase-2 in lung cancer
K Riedla, K Krysana, M Põlda, H Dalwadia… - Drug Resistance …, 2004 - academia.edu
Lung cancer is the leading cause of cancer death in the United States. Although the low 5-
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …
Multifaceted roles of cyclooxygenase-2 in lung cancer.
K Riedl, K Krysan, M Põld, H Dalwadi… - … and Commentaries in …, 2004 - europepmc.org
Lung cancer is the leading cause of cancer death in the United States. Although the low 5-
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …
Multifaceted roles of cyclooxygenase-2 in lung cancer
K Riedl, K Krysan, M Põld… - Drug resistance …, 2004 - pubmed.ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer death in the United States. Although the low 5-
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …
Multifaceted roles of cyclooxygenase-2 in lung cancer
K Riedl, K Krysan, M Põld, H Dalwadi… - Drug Resistance …, 2004 - infona.pl
Lung cancer is the leading cause of cancer death in the United States. Although the low 5-
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …
[引用][C] Multifaceted roles of cyclooxygenase-2 in lung cancer
K Riedl, K Krysan, M Põld, H Dalwadi… - Drug Resistance …, 2004 - cir.nii.ac.jp
Multifaceted roles of cyclooxygenase-2 in lung cancer | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[PDF][PDF] Multifaceted roles of cyclooxygenase-2 in lung cancer
K Riedla, K Krysana, M Põlda, H Dalwadia… - Drug Resistance …, 2004 - academia.edu
Lung cancer is the leading cause of cancer death in the United States. Although the low 5-
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …
Multifaceted roles of cyclooxygenase-2 in lung cancer
K Riedl, K Krysan, M Põld, H Dalwadi… - Drug Resistance …, 2004 - infona.pl
Lung cancer is the leading cause of cancer death in the United States. Although the low 5-
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …
year survival rate (under 15%) has changed minimally in the last 25 years, new agents and …